Recent Articles from Chartmill
ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
Website: https://www.chartmill.com
Shoulder Innovations (NYSE:SI) Posts In-Line Q2 Results, Raises Full-Year Outlookchartmill.com
Via Chartmill · August 6, 2026
Sezzle (NASDAQ:SEZL) Beats Q2 Estimates but Stock Slides on Profit-Takingchartmill.com
Via Chartmill · August 6, 2026
RLJ Lodging Trust (NYSE:RLJ) Beats Q2 Estimates and Raises Full-Year Guidancechartmill.com
Via Chartmill · August 6, 2026
Revelation Biosciences (NASDAQ:REVB) Surges on Pipeline Progress Despite Q2 Earnings Misschartmill.com
Via Chartmill · August 6, 2026
Avita Medical (NASDAQ:RCEL) Beats Q2 Estimates and Raises Full-Year Guidancechartmill.com
Via Chartmill · August 6, 2026
PRA Group (NASDAQ:PRAA) Jumps 7.4% After Blowout Q2 Earnings Beatchartmill.com
Via Chartmill · August 6, 2026
Post Holdings (NYSE:POST) Drops as Revenue Miss Overshadows EPS Beatchartmill.com
Via Chartmill · August 6, 2026
Progyny (NASDAQ:PGNY) Shares Slide After Q2 Beat Overshadowed by Weak Guidancechartmill.com
Via Chartmill · August 6, 2026
PDF Solutions (NASDAQ:PDFS) Posts Inline Q2 Results but Shares Slip After Hourschartmill.com
Via Chartmill · August 6, 2026
PureCycle Technologies (NASDAQ:PCT) Shares Decline on Q2 Revenue and EPS Misschartmill.com
Via Chartmill · August 6, 2026
Outset Medical (NASDAQ:OM) Jumps 19% on Q2 Revenue Beat, HCA Dealchartmill.com
Via Chartmill · August 6, 2026
NerdWallet (NASDAQ:NRDS) Surges After Q3 Guidance Beats Estimates, Offsetting Mixed Q2 Resultschartmill.com
Via Chartmill · August 6, 2026
Cloudflare (NYSE:NET) Jumps 16% on Q2 Beat and Strong Full-Year Guidancechartmill.com
Via Chartmill · August 6, 2026
MicroVision (NASDAQ:MVIS) Rises on Commercial Pipeline Progress Despite Q2 Revenue Misschartmill.com
Via Chartmill · August 6, 2026
Morgan Stanley Direct Lending (NYSE:MSDL) Q2 NII Matches Estimates, Revenue Slightly Belowchartmill.com
Via Chartmill · August 6, 2026
Maravai Lifesciences (NASDAQ:MRVI) Shares Slide Despite Q2 Beat as Full-Year Revenue Outlook Weighschartmill.com
Via Chartmill · August 6, 2026
WM Technology (NASDAQ:MAPS) Misses Q2 Estimates and Guides to Sequential Revenue Declinechartmill.com
Via Chartmill · August 6, 2026
Main Street Capital (NYSE:MAIN) Reports Mixed Q2 Results: Revenue Beats, EPS Slightly Misseschartmill.com
Via Chartmill · August 6, 2026
Lineage Cell Therapeutics (NYSEARCA:LCTX) Slips on Q2 Revenue Miss, but EPS In Line and Pipeline Advanceschartmill.com
Via Chartmill · August 6, 2026
Innodata (NASDAQ:INOD) Smashes Q2 Estimates on Revenue and Profit, Stock Surgeschartmill.com
Via Chartmill · August 6, 2026
Inogen (NASDAQ:INGN) Falls as Revenue Misses and Full-Year Guidance Trails Estimateschartmill.com
Via Chartmill · August 6, 2026
Indie Semiconductor (NASDAQ:INDI) Shares Surge as Q2 Results Top Estimateschartmill.com
Via Chartmill · August 6, 2026
Granite Ridge Resources (NYSE:GRNT) Beats Q2 Earnings Estimates, Revenue Slightly Misseschartmill.com
Via Chartmill · August 6, 2026
Gevo Inc (NASDAQ:GEVO) Gains on Narrower Q2 Loss and Doubled 2026 EBITDA Outlookchartmill.com
Via Chartmill · August 6, 2026
Gladstone Investment (NASDAQ:GAIN) Beats Fiscal Q1 Estimates on Strong Investment Incomechartmill.com
Via Chartmill · August 6, 2026
Genpact (NYSE:G) Slips After Inline Q2 Resultschartmill.com
Via Chartmill · August 6, 2026
CareTrust REIT (NYSE:CTRE) Beats Q2 Estimates and Raises Full-Year Guidancechartmill.com
Via Chartmill · August 6, 2026
Corvus Pharmaceuticals (NASDAQ:CRVS) Misses Q2 Loss Estimates as Clinical-Stage Spending Continueschartmill.com
Via Chartmill · August 6, 2026
Concentra (NYSE:CON) Beats Q2 Estimates and Raises Guidance, but Shares Stay Flatchartmill.com
Via Chartmill · August 6, 2026
Celldex Therapeutics (NASDAQ:CLDX) Q2 EPS Beat Overshadowed by Revenue Miss and Prurigo Nodularis Discontinuationchartmill.com
Via Chartmill · August 6, 2026
Consensus Cloud Solution (NASDAQ:CCSI) Tumbles on Weak Outlook Despite In-Line Q2chartmill.com
Via Chartmill · August 6, 2026
Amphastar Pharmaceuticals (NASDAQ:AMPH) Beats Q2 Earnings Estimates, Shares Rise After Hourschartmill.com
Via Chartmill · August 6, 2026
AMN Healthcare (NYSE:AMN) Surges After Blowout Q2 Earnings Beatchartmill.com
Via Chartmill · August 6, 2026
American International Group (NYSE:AIG) Beats Q2 Earnings, But Revenue Misseschartmill.com
Via Chartmill · August 6, 2026
Senseonics Holdings (NASDAQ:SENS) Jumps on Q2 Revenue Beat and Raised Full-Year Guidancechartmill.com
Via Chartmill · August 6, 2026
ResMed (NYSE:RMD) Q4 Results Inline with Estimates; Stock Slips 1.9%chartmill.com
Via Chartmill · August 6, 2026
Ouster (NASDAQ:OUST) Drops on Soft Q3 Guidance Despite Q2 Beatchartmill.com
Via Chartmill · August 6, 2026
Octave Specialty Group (NYSE:OSG) Revenue Beats but Adjusted Loss Widens in Q2chartmill.com
Via Chartmill · August 6, 2026
Omada Health (NASDAQ:OMDA) Soars on Q2 Beat, Record Margins, and Raised Guidancechartmill.com
Via Chartmill · August 6, 2026
Nerdy (NYSE:NRDY) Slides After Q2 Report as Weak Guidance Overshadows Resultschartmill.com
Via Chartmill · August 6, 2026
Northern Oil and Gas (NYSE:NOG) Beats Q2 Estimates but Stock Tepid on Operational Disruptions and Hedging Costschartmill.com
Via Chartmill · August 6, 2026
Nelnet (NYSE:NNI) Shares Rise Despite Q2 EPS Misschartmill.com
Via Chartmill · August 6, 2026
Discover the top S&P500 movers in Thursday's after-hours session.chartmill.com
Via Chartmill · August 6, 2026
Manitowoc (NYSE:MTW) Beats Q2 Estimates, Raises Full-Year Guidancechartmill.com
Via Chartmill · August 6, 2026
Monster Beverage (NASDAQ:MNST) Slips After Inline Q2 EPSchartmill.com
Via Chartmill · August 6, 2026
AEYE (NASDAQ:LIDR) Q2 Revenue Misses Estimates but Commercial Pipeline Reaches Recordchartmill.com
Via Chartmill · August 6, 2026
INmune Bio (NASDAQ:INMB) Beats Q2 Loss Estimates but Shares Tumble on Business Updatechartmill.com
Via Chartmill · August 6, 2026
Curious about the stocks that are showing activity after the closing bell on Thursday?chartmill.com
Via Chartmill · August 6, 2026
ICF International (NASDAQ:ICFI) Reports Mixed Q2 as Earnings Beat, Revenue Misschartmill.com
Via Chartmill · August 6, 2026
Health Catalyst (NASDAQ:HCAT) Tumbles 24% on Weak Guidance Despite Q2 Earnings Beatchartmill.com
Via Chartmill · August 6, 2026
Expensify (NASDAQ:EXFY) Shares Surge After Q2 Earnings Beat as New Platform Momentum Accelerateschartmill.com
Via Chartmill · August 6, 2026
Doximity (NYSE:DOCS) Surges on AI Engagement Momentum Despite EPS Miss and Soft Guidancechartmill.com
Via Chartmill · August 6, 2026
Denali Therapeutics (NASDAQ:DNLI) Drops as Q2 AVLAYAH Revenue Misses Estimateschartmill.com
Via Chartmill · August 6, 2026
Definium Therapeutics (NASDAQ:DFTX) Slides After Q2 Loss Misses Estimates on Warrant Chargechartmill.com
Via Chartmill · August 6, 2026
Cytokinetics (NASDAQ:CYTK) Beats Q2 Estimates on Strong MYQORZO Launchchartmill.com
Via Chartmill · August 6, 2026
Cryoport (NASDAQ:CYRX) Reports In-Line Q2 Results as Stock Edges Higherchartmill.com
Via Chartmill · August 6, 2026
Corsair Gaming (NASDAQ:CRSR) Beats Q2 Estimates and Raises Full-Year Outlookchartmill.com
Via Chartmill · August 6, 2026
Aflac (NYSE:AFL) Posts Inline Q2 2026 Resultschartmill.com
Via Chartmill · August 6, 2026
Which dow jones stocks are moving on Thursday?chartmill.com
Via Chartmill · August 6, 2026
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Via Chartmill · August 6, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · August 6, 2026
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.chartmill.com
Via Chartmill · August 6, 2026
Scholar Rock (NASDAQ:SRRK) Rallies 17% as Regulatory Catalysts Outweigh In-Line Q2 Resultschartmill.com
Via Chartmill · August 6, 2026
Sempra (NYSE:SRE) Shares Slide on Q2 Revenue Miss Despite Earnings Beatchartmill.com
Via Chartmill · August 6, 2026
Curious about the most active S&P500 stocks in today's session?chartmill.com
Via Chartmill · August 6, 2026
Thursday's session: most active stockschartmill.com
Via Chartmill · August 6, 2026
On Thursday, there are stocks with unusual volume. Let's take a look.chartmill.com
Via Chartmill · August 6, 2026
Thursday's session: top gainers and losers in the dow jones indexchartmill.com
Via Chartmill · August 6, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · August 6, 2026
Suburban Propane Partners (NYSE:SPH) Reports Wider Q3 Loss, Revenue In Linechartmill.com
Via Chartmill · August 6, 2026
Sunstone Hotel Investors (NYSE:SHO) Beats Q2 Estimates, Raises Outlook After Hyatt Regency Salechartmill.com
Via Chartmill · August 6, 2026
Sotera Health (NASDAQ:SHC) Beats Q2 Estimates and Raises Guidance, But Shares Slipchartmill.com
Via Chartmill · August 6, 2026
Let's have a look at the top gainers and losers in the middle of the day of today's session.chartmill.com
Via Chartmill · August 6, 2026